Emglif 25 Tablet

About Emglif 25 Tablet

Emglif 25 25 mg is a tablet product of Orion Pharma Ltd. that contains Empagliflozin. It is not a replacement for healthy eating and physical activity.

There are 23 brands of Empagliflozin listed in Bangladesh. The lowest listed price is Adempa 10 mg Tablet at ৳ 25.00 per unit.

What is Emglif 25 Tablet?

Emglif 25 is a tablet from Orion Pharma Ltd., with the generic name Empagliflozin. This kind of medicine works on the kidneys, where it reduces the reabsorption of glucose and increases the amount of glucose passed out in the urine. Ask your doctor or pharmacist if you are unsure about it.

Uses of Emglif 25

It is not a replacement for healthy eating and physical activity. Your doctor will decide if it is suitable for you.

How to use Emglif 25

If you are not sure how or when to take it, or what to do if you miss a dose, ask your doctor or pharmacist. Swallow the tablet with water. Emglif 25 is taken by mouth. Complete the course exactly as prescribed.

Side effects of Emglif 25

Others common side effects includes dehydration, hypotension, weakness, dizziness and increased thirstiness. If you notice any side effect, or if something worries you, tell your doctor or pharmacist. The most common adverse reactions associated with Empagliflozin are urinary tract infections and female genital mycotic infections. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

Use in pregnancy only if the doctor decides the benefit outweighs the risk. Do not use Emglif 25 if you have had a serious allergic reaction to Empagliflozin or to any of its ingredients. It is not for people with severe kidney problems, end-stage kidney disease or those on dialysis. Tell your doctor about your kidney function, other medicines such as diuretics, insulin or medicines that raise insulin, and any illness or surgery.

Frequently asked questions

What does Emglif 25 treat?

It is not a replacement for healthy eating and physical activity. Your doctor will decide if it is suitable for you.

How is Emglif 25 used?

If you are not sure how or when to take it, or what to do if you miss a dose, ask your doctor or pharmacist. Swallow the tablet with water.

Can Emglif 25 cause side effects?

Others common side effects includes dehydration, hypotension, weakness, dizziness and increased thirstiness. If you notice any side effect, or if something worries you, tell your doctor or pharmacist.

Can I use Emglif 25 in pregnancy or while breastfeeding?

Use in pregnancy only if the doctor decides the benefit outweighs the risk. Do not use Emglif 25 if you have had a serious allergic reaction to Empagliflozin or to any of its ingredients.

Indications

Empagliflozin is indicated in:
  • As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
  • To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.

Pharmacology

Empagliflozin is a sodium glucose co-transporter-2 (SGLT-2) inhibitor. SGLT2 co-transporters are responsible for reabsorption of glucose from the glomerular filtrate in the kidney. The glucuretic effect resulting from SGLT2 inhibition reduces renal absorption and lowers the renal threshold for glucose, resulting in increased glucose excretion. Additionally, it contributes to reduced hyperglycaemia, assists weight loss, and reduces blood pressure.

Dosage & Administration

The recommended dose of Empagliflozin is 10 mg once daily, taken in the morning, with or without food. In patients tolerating Empagliflozin, the dose may be increased to 25 mg once daily. In patients with volume depletion, correcting this condition prior to initiation of Empagliflozin is recommended.

Interaction

Diuretics: Co-administration of Empagliflozin with diuretics resulted in increased urine volume. 

Insulin or Insulin Secretagogues: Co-administration of Empagliflozin with insulin or insulin secretagogues increases the risk for hypoglycemia. 

Positive Urine Glucose Test: Monitoring glycemic control with urine glucose tests is not recommended in patients taking SGLT2 inhibitors as SGLT2 inhibitors increase urinary glucose excretion and will lead to positive urine glucose tests. Use alternative methods to monitor glycemic control. 

Interference with 1,5-anhydroglucitol (1,5-AG) Assay: Monitoring glycemic control with 1,5-AG assay is not recommended as measurements of 1,5-AG are unreliable in assessing glycemic control in patients taking SGLT2 inhibitors. Use alternative methods to monitor glycemic control.

Contraindications

Empagliflozin is contraindicated in patients with history of serious hypersensitivity reaction to Empagliflozin or any of its ingredients, severe renal impairment, end-stage renal disease, or dialysis.

Side Effects

The most common adverse reactions associated with Empagliflozin are urinary tract infections and female genital mycotic infections. Others common side effects includes dehydration, hypotension, weakness, dizziness and increased thirstiness.

Pregnancy & Lactation

There are no adequate and well-controlled studies of Empagliflozin in pregnant women. Empagliflozin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known if Empagliflozin is excreted in human milk. It is not recommended when breastfeeding.

Precautions & Warnings

Assessment of renal function is recommended prior to initiation of Empagliflozin and periodically thereafter. Empagliflozin should not initiated in patients with an eGFR less than 45 ml/min/1.73 m2. No dose adjustment is needed in patients with an eGFR greater than or equal to 45 ml/min/1.73 m2.

Overdose Effects

In the event of an overdose with Empagliflozin the usual supportive measures (e.g., remove unabsorbed material from the gastrointestinal tract, perform clinical monitoring, and institute supportive treatment) should be employed. Removal of Empagliflozin by hemodialysis has not been studied.

Storage Conditions

Keep in a cool & dry place (below 30° C), protected from light & moisture. Keep out of the reach of children.

Alternative brands of Empagliflozin

Other brands with the same generic name, cheapest first.

See all 23 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.